Statistical analysis of tumor growth in BALB/c wildtype, CD1KO, and Jα18KO mice inoculated with NS0-V or NS0-CD1 cells and treated with an isotype control or anti-CD1d mAb (n = 8 mice/group)*
Tumor and mouse group† . | In vivo CD1d block . | |||
---|---|---|---|---|
Isotype control . | Anti-mouse CD1d . | |||
P . | Significance‡ . | P . | Significance . | |
NS0-V with wildtype and CD1KO | .144 | NS§ | .843 | NS |
NS0-V with wildtype and Jα18KO | .021 | S¶ | .779 | NS |
NS0-V with CD1KO and Jα18 KO | <.001 | S | .612 | NS |
NS0-CD1 with wildtype and CD1KO | .283 | NS | .846 | NS |
NS0-CD1 with wildtype and Jα18 KO | .040 | S | .926 | NS |
NS0-CD1 with CD1KO and Jα18KO | .006 | S | .943 | NS |
Wildtype with NS0-V and NS0-CD1 | .609 | NS | .665 | NS |
CD1KO with NS0-V and NS0-CD1 | .317 | NS | .690 | NS |
Jα18KO with NS0-V and NS0-CD1 | .364 | NS | .943 | NS |
Tumor and mouse group† . | In vivo CD1d block . | |||
---|---|---|---|---|
Isotype control . | Anti-mouse CD1d . | |||
P . | Significance‡ . | P . | Significance . | |
NS0-V with wildtype and CD1KO | .144 | NS§ | .843 | NS |
NS0-V with wildtype and Jα18KO | .021 | S¶ | .779 | NS |
NS0-V with CD1KO and Jα18 KO | <.001 | S | .612 | NS |
NS0-CD1 with wildtype and CD1KO | .283 | NS | .846 | NS |
NS0-CD1 with wildtype and Jα18 KO | .040 | S | .926 | NS |
NS0-CD1 with CD1KO and Jα18KO | .006 | S | .943 | NS |
Wildtype with NS0-V and NS0-CD1 | .609 | NS | .665 | NS |
CD1KO with NS0-V and NS0-CD1 | .317 | NS | .690 | NS |
Jα18KO with NS0-V and NS0-CD1 | .364 | NS | .943 | NS |
Mice were inoculated with 107 tumor cells/mouse and 50 μg of isotype or anti-mouse CD1d mAb on days −1, 5, 10, 20, 30, 40, and 50 intraperitoneally.
Comparisons were made between the different combinations of groups in order to determine the statistical significance of the analyses.
The P values are based on the log-rank test comparing either 2 groups of mice with 1 cell line or 2 cell lines with 1 group of mice as indicated.
Not significant.
Significant (entries in bold).